Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duygu Yilmaz

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 9, 2022
Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatmentDuygu Yilmaz Usta, Burcu Timur, Zeynep Safak Teksin
Accounts of Chemical Research|April 20, 2013
Bright ion channels and lipid bilayersWiktor Szymański, Duygu Yilmaz, Armağan Koçer, et al.
European Biophysics Journal : EBJ|August 20, 2015
Study of light-induced MscL gating by EPR spectroscopyDuygu Yilmaz, Anna I Dimitrova, Martin Walko, et al.
International Journal of Pharmaceutics|July 11, 2023
Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex-vivo imagingDuygu Yilmaz Usta, Seval Olgac, Burcu Timur, et al.
Thescientificworldjournal|July 22, 2014
Introducing the MCHF/OVRP/SDMP: multicapacitated/heterogeneous fleet/open vehicle routing problems with split deliveries and multiproductsDuygu Yilmaz Eroglu, Burcu Caglar Gencosman, Fatih Cavdur, et al.
Drug Discovery Today|March 8, 2022
Advanced molecular imaging for the characterisation of complex medicinesDuygu Yilmaz, Paul S Sharp, Martin J Main, et al.
Leukemia Research|April 17, 2010
DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemiaTugba Boyunegmez Tumer, Duygu Yilmaz, Cihan Tanrikut, et al.
Protein Science : a Publication of the Protein Society|May 14, 2015
Top-down mass spectrometry of intact membrane protein complexes reveals oligomeric state and sequence information in a single experimentAlbert Konijnenberg, Ludovic Bannwarth, Duygu Yilmaz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 10, 2025
Comparison of in vitro lipolysis, sequential lipolysis - ex vivo permeability, and simultaneous lipolysis - in situ perfusion for exemestane-loaded lipid-based formulationsBurcu Timur, Seval Olgac, Duygu Yilmaz Usta, et al.
Pediatric Research|March 16, 2026
Modified stress scores enhance prediction of outcomes after pediatric cardiac surgeryGokcen Ozcifci, Fatih Durak, Emine Pinar Kulluoglu, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 9, 2022
Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatmentDuygu Yilmaz Usta, Burcu Timur, Zeynep Safak Teksin
Accounts of Chemical Research|April 20, 2013
Bright ion channels and lipid bilayersWiktor Szymański, Duygu Yilmaz, Armağan Koçer, et al.
European Biophysics Journal : EBJ|August 20, 2015
Study of light-induced MscL gating by EPR spectroscopyDuygu Yilmaz, Anna I Dimitrova, Martin Walko, et al.
International Journal of Pharmaceutics|July 11, 2023
Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex-vivo imagingDuygu Yilmaz Usta, Seval Olgac, Burcu Timur, et al.
Thescientificworldjournal|July 22, 2014
Introducing the MCHF/OVRP/SDMP: multicapacitated/heterogeneous fleet/open vehicle routing problems with split deliveries and multiproductsDuygu Yilmaz Eroglu, Burcu Caglar Gencosman, Fatih Cavdur, et al.
Drug Discovery Today|March 8, 2022
Advanced molecular imaging for the characterisation of complex medicinesDuygu Yilmaz, Paul S Sharp, Martin J Main, et al.
Leukemia Research|April 17, 2010
DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemiaTugba Boyunegmez Tumer, Duygu Yilmaz, Cihan Tanrikut, et al.
Protein Science : a Publication of the Protein Society|May 14, 2015
Top-down mass spectrometry of intact membrane protein complexes reveals oligomeric state and sequence information in a single experimentAlbert Konijnenberg, Ludovic Bannwarth, Duygu Yilmaz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 10, 2025
Comparison of in vitro lipolysis, sequential lipolysis - ex vivo permeability, and simultaneous lipolysis - in situ perfusion for exemestane-loaded lipid-based formulationsBurcu Timur, Seval Olgac, Duygu Yilmaz Usta, et al.
Pediatric Research|March 16, 2026
Modified stress scores enhance prediction of outcomes after pediatric cardiac surgeryGokcen Ozcifci, Fatih Durak, Emine Pinar Kulluoglu, et al.
Pageof 3